Q4 2023
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | Sell | EXELIXIS INC | $63,292,817 | -7.7% | 2,638,300 | -15.9% | 79.10% | -11.0% |
Q3 2023
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | Sell | EXELIXIS INC | $68,569,670 | -30.1% | 3,138,200 | -38.9% | 88.89% | +4.3% |
ESPR | Sell | ESPERION THERAPEUTICS INC | $3,715,474 | -39.3% | 3,791,300 | -13.9% | 4.82% | -9.4% |
INDA | Sell | ISHARES MSCI INDIA ETF | $2,627,262 | -53.5% | 59,400 | -54.0% | 3.41% | -30.5% |
EPI | Sell | WISDOMTREE INDIA EARNINGS FUND | $2,231,332 | -57.8% | 60,700 | -60.0% | 2.89% | -36.9% |
Q2 2023
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $98,144,335 | – | 5,135,758 | – | 85.20% | – |
ESPR | New | ESPERION THERAPEUTICS INC | $6,120,132 | – | 4,402,973 | – | 5.31% | – |
INDA | New | ISHARES MSCI INDIA ETF | $5,646,040 | – | 129,200 | – | 4.90% | – |
EPI | New | WISDOMTREE INDIA EARNINGS FUND | $5,282,640 | – | 151,800 | – | 4.59% | – |
Q4 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EPI | Exit | WISDOMTREE INDIA EARNINGS FUND | $0 | – | -213,800 | – | -4.34% | – |
INDA | Exit | ISHARES MSCI INDIA ETF | $0 | – | -171,200 | – | -4.64% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC | $0 | – | -4,468,835 | – | -19.92% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -6,816,300 | – | -71.10% | – |
Q3 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | Sell | EXELIXIS INC | $106,879,000 | -33.5% | 6,816,300 | -11.7% | 71.10% | -10.5% |
Q2 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $160,736,000 | – | 7,720,300 | – | 79.48% | – |
ESPR | New | ESPERION THERAPEUTICS INC | $28,421,000 | – | 4,468,835 | – | 14.05% | – |
INDA | New | ISHARES MSCI INDIA ETF | $6,740,000 | – | 171,200 | – | 3.33% | – |
EPI | New | WISDOMTREE INDIA EARNINGS FUND | $6,341,000 | – | 213,800 | – | 3.14% | – |
Q4 2021
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EPI | Exit | WISDOMTREE INDIA EARNINGS FUND | $0 | – | -400,000 | – | -5.14% | – |
INDA | Exit | ISHARES MSCI INDIA ETF | $0 | – | -320,000 | – | -5.35% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC | $0 | – | -2,818,835 | – | -11.67% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -10,719,400 | – | -77.84% | – |
Q2 2021
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $195,307,000 | – | 10,719,400 | – | 69.10% | – |
ESPR | New | ESPERION THERAPEUTICS INC | $59,618,000 | – | 2,818,835 | – | 21.09% | – |
INDA | New | ISHARES MSCI INDIA ETF | $14,160,000 | – | 320,000 | – | 5.01% | – |
EPI | New | WISDOMTREE INDIA EARNINGS FUND | $13,544,000 | – | 400,000 | – | 4.79% | – |
Q4 2020
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EPI | Exit | WISDOMTREE INDIA EARNINGS FUND | $0 | – | -400,000 | – | -2.12% | – |
INDA | Exit | ISHARES MSCI INDIA ETF | $0 | – | -320,000 | – | -2.43% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -750,000 | – | -2.78% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC | $0 | – | -2,679,835 | – | -22.32% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -12,841,798 | – | -70.35% | – |
Q3 2020
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CLDX | Exit | CELLDEX THERAPEUTICS | $0 | – | -196,846 | – | -0.54% | – |
Q2 2020
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $304,864,000 | – | 12,841,798 | – | 63.94% | – |
ESPR | New | ESPERION THERAPEUTICS INC | $137,502,000 | – | 2,679,835 | – | 28.84% | – |
ALKS | New | ALKERMES PLC | $14,553,000 | – | 750,000 | – | 3.05% | – |
INDA | New | ISHARES MSCI INDIA ETF | $9,286,000 | – | 320,000 | – | 1.95% | – |
EPI | New | WISDOMTREE INDIA EARNINGS FUND | $8,012,000 | – | 400,000 | – | 1.68% | – |
CLDX | New | CELLDEX THERAPEUTICS | $2,558,000 | – | 196,846 | – | 0.54% | – |
Q4 2019
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CLDX | Exit | CELLDEX THERAPEUTICS | $0 | – | -420,846 | – | -0.22% | – |
SQQQ | Exit | PROSHARES ULTRAPRO SHORT QQQ ETF | $0 | – | -71,250 | – | -0.56% | – |
SPXU | Exit | PROSHARES ULTRAPRO SHORT S&P 500 ETF | $0 | – | -105,000 | – | -0.66% | – |
SDS | Exit | PROSHARES ULTRASHORT S&P 500 ETF | $0 | – | -115,000 | – | -0.83% | – |
EPI | Exit | WISDOMTREE INDIA EARNINGS FUND | $0 | – | -400,000 | – | -2.32% | – |
INDA | Exit | ISHARES MSCI INDIA ETF | $0 | – | -320,000 | – | -2.62% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -892,400 | – | -4.24% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC | $0 | – | -2,679,835 | – | -23.93% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -15,001,073 | – | -64.62% | – |
Q2 2019
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $320,572,000 | – | 15,001,073 | – | 64.48% | – |
ESPR | New | ESPERION THERAPEUTICS INC | $124,665,000 | – | 2,679,835 | – | 25.08% | – |
ALKS | New | ALKERMES PLC | $20,114,000 | – | 892,400 | – | 4.05% | – |
INDA | New | ISHARES MSCI INDIA ETF | $11,296,000 | – | 320,000 | – | 2.27% | – |
EPI | New | WISDOMTREE INDIA EARNINGS FUND | $10,424,000 | – | 400,000 | – | 2.10% | – |
SDS | New | PROSHARES ULTRASHORT S&P 500 ETF | $3,532,000 | – | 115,000 | – | 0.71% | – |
SPXU | New | PROSHARES ULTRAPRO SHORT S&P 500 ETF | $2,921,000 | – | 105,000 | – | 0.59% | – |
SQQQ | New | PROSHARES ULTRAPRO SHORT QQQ ETF | $2,504,000 | – | 71,250 | – | 0.50% | – |
CLDX | New | CELLDEX THERAPEUTICS | $1,127,000 | – | 420,846 | – | 0.23% | – |
Q4 2018
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CLDX | Exit | CELLDEX THERAPEUTICS | $0 | – | -6,312,700 | – | -0.61% | – |
INDA | Exit | ISHARES MSCI INDIA ETF | $0 | – | -290,000 | – | -2.02% | – |
EPI | Exit | WISDOMTREE INDIA EARNINGS FUND | $0 | – | -400,000 | – | -2.07% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -1,030,639 | – | -9.40% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC | $0 | – | -2,629,835 | – | -25.08% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -15,966,038 | – | -60.81% | – |
Q2 2018
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $343,589,000 | – | 15,966,038 | – | 67.11% | – |
ESPR | New | ESPERION THERAPEUTICS INC | $103,063,000 | – | 2,629,835 | – | 20.13% | – |
ALKS | New | ALKERMES PLC | $42,421,000 | – | 1,030,639 | – | 8.29% | – |
EPI | New | WISDOMTREE INDIA EARNINGS FUND | $10,068,000 | – | 400,000 | – | 1.97% | – |
INDA | New | ISHARES MSCI INDIA ETF | $9,654,000 | – | 290,000 | – | 1.89% | – |
CLDX | New | CELLDEX THERAPEUTICS | $3,179,000 | – | 6,312,700 | – | 0.62% | – |
Q4 2017
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
INDA | Exit | ISHARES MSCI INDIA ETF | $0 | – | -290,000 | – | -1.45% | – |
EPI | Exit | WISDOMTREE INDIA EARNINGS FUND | $0 | – | -400,000 | – | -1.53% | – |
SDS | Exit | PROSHARES ULTRASHORT S&P500 | $0 | – | -315,000 | – | -2.23% | – |
SPXU | Exit | PROSHARES ULTRAPRO SHORT S&P500 | $0 | – | -1,230,000 | – | -2.58% | – |
CLDX | Exit | CELLDEX THERAPEUTICS | $0 | – | -6,312,700 | – | -2.74% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -1,030,639 | – | -7.95% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC | $0 | – | -2,294,935 | – | -17.46% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -17,416,738 | – | -64.06% | – |
Q3 2017
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | Sell | EXELIXIS INC | $422,007,000 | -15.3% | 17,416,738 | -13.9% | 64.06% | -14.5% |
ESPR | Buy | ESPERION THERAPEUTICS INC | $115,022,000 | +339.1% | 2,294,935 | +305.5% | 17.46% | +343.1% |
CLDX | Buy | CELLDEX THERAPEUTICS | $18,054,000 | +26.0% | 6,312,700 | +8.8% | 2.74% | +27.1% |
SDS | Sell | PROSHARES ULTRASHORT S&P500 | $14,694,000 | -8.0% | 315,000 | -75.0% | 2.23% | -7.2% |
EPI | Sell | WISDOMTREE INDIA EARNINGS FUND | $10,068,000 | -34.8% | 400,000 | -36.5% | 1.53% | -34.2% |
INDA | Sell | ISHARES MSCI INDIA ETF | $9,526,000 | -38.2% | 290,000 | -39.6% | 1.45% | -37.6% |
Q2 2017
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $498,258,000 | – | 20,229,713 | – | 74.97% | – |
ALKS | New | ALKERMES PLC | $59,746,000 | – | 1,030,639 | – | 8.99% | – |
ESPR | New | ESPERION THERAPEUTICS INC | $26,194,000 | – | 566,000 | – | 3.94% | – |
SPXU | New | PROSHARES ULTRAPRO SHORT S&P500 | $19,249,000 | – | 1,230,000 | – | 2.90% | – |
SDS | New | PROSHARES ULTRASHORT S&P500 | $15,977,000 | – | 1,260,000 | – | 2.40% | – |
EPI | New | WISDOMTREE INDIA EARNINGS FUND | $15,441,000 | – | 630,000 | – | 2.32% | – |
INDA | New | ISHARES MSCI INDIA ETF | $15,408,000 | – | 480,000 | – | 2.32% | – |
CLDX | New | CELLDEX THERAPEUTICS | $14,326,000 | – | 5,800,000 | – | 2.16% | – |
Q4 2016
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VVUS | Exit | VIVUS INC | $0 | – | -1,600,000 | – | -0.50% | – |
INDA | Exit | ISHARES MSCI INDIA ETF | $0 | – | -480,000 | – | -3.91% | – |
EPI | Exit | WISDOMTREE INDIA EARNINGS FUND | $0 | – | -670,000 | – | -4.01% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -1,030,639 | – | -13.42% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -22,070,213 | – | -78.16% | – |
Q2 2016
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $172,368,000 | – | 22,070,213 | – | 70.17% | – |
ALKS | New | ALKERMES PLC | $44,544,000 | – | 1,030,639 | – | 18.13% | – |
EPI | New | WISDOMTREE INDIA EARNINGS FUND | $13,527,000 | – | 670,000 | – | 5.51% | – |
INDA | New | ISHARES MSCI INDIA ETF | $13,402,000 | – | 480,000 | – | 5.46% | – |
VVUS | New | VIVUS INC | $1,792,000 | – | 1,600,000 | – | 0.73% | – |
Q4 2015
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ITEK | Exit | INOTEK PHARMACEUTICALS | $0 | – | -51,111 | – | -0.25% | – |
VVUS | Exit | VIVUS INC | $0 | – | -2,965,616 | – | -2.56% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -1,030,639 | – | -31.89% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -22,070,213 | – | -65.29% | – |
Q3 2015
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | Buy | EXELIXIS INC | $123,814,000 | +72.7% | 22,070,213 | +15.7% | 65.29% | +32.0% |
ITEK | New | INOTEK PHARMACEUTICALS | $480,000 | – | 51,111 | – | 0.25% | – |
Q2 2015
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $71,704,000 | – | 19,070,213 | – | 49.45% | – |
ALKS | New | ALKERMES PLC | $66,311,000 | – | 1,030,639 | – | 45.73% | – |
VVUS | New | VIVUS INC | $6,998,000 | – | 2,965,616 | – | 4.83% | – |
Q4 2014
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VVUS | Exit | VIVUS INC | $0 | – | -2,965,616 | – | -11.87% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -19,070,213 | – | -36.51% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -1,030,639 | – | -51.62% | – |
Q3 2014
Q2 2014
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | New | EXELIXIS INC | $64,648,000 | – | 19,070,213 | – | 48.45% | – |
ALKS | New | ALKERMES PLC | $51,872,000 | – | 1,030,639 | – | 38.88% | – |
VVUS | New | VIVUS INC | $16,910,000 | – | 3,178,616 | – | 12.67% | – |
Q4 2013
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HTZ | Exit | HERTZ GLOBAL HOLDINGS INC | $0 | – | -12,000 | – | -0.04% | – |
INFN | Exit | INFINERA CORP | $0 | – | -24,400 | – | -0.04% | – |
GTE | Exit | GRAN TIERRA ENERGY INC | $0 | – | -63,000 | – | -0.06% | – |
CCL | Exit | CARNIVAL CORPctf | $0 | – | -45,600 | – | -0.21% | – |
HAL | Exit | HALLIBURTON CO | $0 | – | -31,000 | – | -0.21% | – |
MU | Exit | MICRON TECHNOLOGY INC | $0 | – | -155,000 | – | -0.38% | – |
DAL | Exit | DELTA AIR LINES INC | $0 | – | -124,000 | – | -0.41% | – |
BAC | Exit | BANK OF AMERICA CORP | $0 | – | -244,000 | – | -0.48% | – |
VALE | Exit | VALE SA-SP ADRadr | $0 | – | -219,400 | – | -0.48% | – |
APC | Exit | ANADARKO PETROLEUM CORP | $0 | – | -42,000 | – | -0.55% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -55,100 | – | -0.56% | – |
PACD | Exit | PACIFIC DRILLING SA | $0 | – | -365,100 | – | -0.57% | – |
SHPG | Exit | SHIRE PLC-ADRadr | $0 | – | -70,000 | – | -1.18% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -1,050,000 | – | -1.68% | – |
LBTYK | Exit | LIBERTY GLOBAL PLC-SERIES Ccl c | $0 | – | -169,254 | – | -1.80% | – |
OREX | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -2,100,000 | – | -1.82% | – |
WCRX | Exit | WARNER CHILCOTT PLC-CLASS A | $0 | – | -566,000 | – | -1.83% | – |
AAPL | Exit | APPLE INC | $0 | – | -30,000 | – | -2.02% | – |
NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -1,450,000 | – | -2.14% | – |
UHS | Exit | UNIVERSAL HEALTH SERVICES-Bcl b | $0 | – | -210,000 | – | -2.22% | – |
ITMN | Exit | INTERMUNE INC | $0 | – | -1,025,000 | – | -2.22% | – |
SPY | Exit | SPDR S&P 500 ETF TRUSTetf | $0 | – | -107,708 | – | -2.55% | – |
ISIS | Exit | ISIS PHARMACEUTICALS INC | $0 | – | -490,000 | – | -2.59% | – |
DDS | Exit | DILLARDS INC-CL Acl a | $0 | – | -245,000 | – | -2.70% | – |
6107SC | Exit | URS CORP | $0 | – | -377,324 | – | -2.86% | – |
GOOGL | Exit | GOOGLE INC-CL Acl a | $0 | – | -23,452 | – | -2.90% | – |
HPQ | Exit | HEWLETT-PACKARD CO | $0 | – | -1,156,423 | – | -3.42% | – |
LIFE | Exit | LIFE TECHNOLOGIES CORP | $0 | – | -427,000 | – | -4.51% | – |
NYX | Exit | NYSE EURONEXT | $0 | – | -776,070 | – | -4.59% | – |
BKS | Exit | BARNES & NOBLE INC | $0 | – | -2,850,000 | – | -5.20% | – |
VVUS | Exit | VIVUS INC | $0 | – | -4,207,296 | – | -5.52% | – |
JCPNQ | Exit | J.C. PENNEY CO INC | $0 | – | -4,500,000 | – | -5.59% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -1,570,000 | – | -7.44% | – |
ONXX | Exit | ONYX PHARMACEUTICALS INC | $0 | – | -435,000 | – | -7.65% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -12,000,000 | – | -9.85% | – |
MRK | Exit | MERCK & CO. INC. | $0 | – | -1,746,600 | – | -11.73% | – |
Q3 2013
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRK | Sell | MERCK & CO. INC. | $83,154,000 | -4.1% | 1,746,600 | -6.4% | 11.73% | -0.1% |
ONXX | Sell | ONYX PHARMACEUTICALS INC | $54,245,000 | -35.1% | 435,000 | -54.8% | 7.65% | -32.4% |
ALKS | Sell | ALKERMES PLC | $52,783,000 | +8.3% | 1,570,000 | -7.6% | 7.44% | +12.7% |
JCPNQ | New | J.C. PENNEY CO INC | $39,623,000 | – | 4,500,000 | – | 5.59% | – |
BKS | Buy | BARNES & NOBLE INC | $36,879,000 | +164.1% | 2,850,000 | +225.7% | 5.20% | +175.0% |
LIFE | Buy | LIFE TECHNOLOGIES CORP | $31,952,000 | +99.0% | 427,000 | +96.8% | 4.51% | +107.2% |
HPQ | Sell | HEWLETT-PACKARD CO | $24,273,000 | -41.6% | 1,156,423 | -31.0% | 3.42% | -39.2% |
GOOGL | Sell | GOOGLE INC-CL Acl a | $20,542,000 | -73.3% | 23,452 | -73.1% | 2.90% | -72.2% |
6107SC | Buy | URS CORP | $20,281,000 | +19.3% | 377,324 | +4.8% | 2.86% | +24.2% |
DDS | New | DILLARDS INC-CL Acl a | $19,184,000 | – | 245,000 | – | 2.70% | – |
ISIS | Sell | ISIS PHARMACEUTICALS INC | $18,395,000 | +31.7% | 490,000 | -5.8% | 2.59% | +37.1% |
SPY | New | SPDR S&P 500 ETF TRUSTetf | $18,096,000 | – | 107,708 | – | 2.55% | – |
ITMN | Sell | INTERMUNE INC | $15,765,000 | +19.2% | 1,025,000 | -25.5% | 2.22% | +24.1% |
UHS | Buy | UNIVERSAL HEALTH SERVICES-Bcl b | $15,748,000 | +135.2% | 210,000 | +110.0% | 2.22% | +144.9% |
AAPL | Sell | APPLE INC | $14,303,000 | -12.0% | 30,000 | -26.8% | 2.02% | -8.4% |
OREX | Buy | OREXIGEN THERAPEUTICS INC | $12,873,000 | +15.9% | 2,100,000 | +10.5% | 1.82% | +20.7% |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $11,886,000 | +229.0% | 1,050,000 | +288.9% | 1.68% | +242.7% |
PACD | Buy | PACIFIC DRILLING SA | $4,045,000 | +50.4% | 365,100 | +32.8% | 0.57% | +56.6% |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $3,977,000 | – | 55,100 | – | 0.56% | – |
MU | Sell | MICRON TECHNOLOGY INC | $2,708,000 | -18.6% | 155,000 | -33.2% | 0.38% | -15.1% |
HAL | Sell | HALLIBURTON CO | $1,493,000 | -34.9% | 31,000 | -43.6% | 0.21% | -32.2% |
GTE | New | GRAN TIERRA ENERGY INC | $461,000 | – | 63,000 | – | 0.06% | – |
INFN | New | INFINERA CORP | $276,000 | – | 24,400 | – | 0.04% | – |
HTZ | New | HERTZ GLOBAL HOLDINGS INC | $266,000 | – | 12,000 | – | 0.04% | – |
MSFT | Exit | MICROSOFT CORP | $0 | – | -20,000 | – | -0.09% | – |
SQNM | Exit | SEQUENOM INC | $0 | – | -700,000 | – | -0.40% | – |
RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -900,000 | – | -0.41% | – |
INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -250,000 | – | -0.55% | – |
NDAQ | Exit | NASDAQ OMX GROUP/THE | $0 | – | -124,793 | – | -0.55% | – |
ECYT | Exit | ENDOCYTE INC | $0 | – | -335,000 | – | -0.60% | – |
ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -144,647 | – | -0.61% | – |
BMC | Exit | BMC SOFTWARE INC | $0 | – | -147,000 | – | -0.90% | – |
OPTR | Exit | OPTIMER PHARMACEUTICALS INC | $0 | – | -475,000 | – | -0.93% | – |
SFD | Exit | SMITHFIELD FOODS INC | $0 | – | -651,000 | – | -2.89% | – |
BBRY | Exit | RESEARCH IN MOTION | $0 | – | -2,210,000 | – | -3.13% | – |
Q2 2013
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRK | New | MERCK & CO.INC. | $86,704,000 | – | 1,866,600 | – | 11.74% | – |
ONXX | New | ONYX PHARMACEUTICALS INC | $83,530,000 | – | 962,103 | – | 11.31% | – |
GOOGL | New | GOOGLE INC-CL Acl a | $76,856,000 | – | 87,300 | – | 10.41% | – |
EXEL | New | EXELIXIS INC | $54,480,000 | – | 12,000,000 | – | 7.38% | – |
VVUS | New | VIVUS INC | $52,928,000 | – | 4,207,296 | – | 7.17% | – |
ALKS | New | ALKERMES PLC | $48,756,000 | – | 1,700,000 | – | 6.60% | – |
HPQ | New | HEWLETT-PACKARD CO | $41,575,000 | – | 1,676,423 | – | 5.63% | – |
NYX | New | NYSE EURONEXT | $32,129,000 | – | 776,070 | – | 4.35% | – |
BBRY | New | RESEARCH IN MOTION | $23,117,000 | – | 2,210,000 | – | 3.13% | – |
SFD | New | SMITHFIELD FOODS INC | $21,320,000 | – | 651,000 | – | 2.89% | – |
6107SC | New | URS CORP | $16,999,000 | – | 360,000 | – | 2.30% | – |
NKTR | New | NEKTAR THERAPEUTICS | $16,748,000 | – | 1,450,000 | – | 2.27% | – |
AAPL | New | APPLE INC | $16,258,000 | – | 41,000 | – | 2.20% | – |
LIFE | New | LIFE TECHNOLOGIES CORP | $16,058,000 | – | 217,000 | – | 2.18% | – |
ISIS | New | ISIS PHARMACEUTICALS INC | $13,972,000 | – | 520,000 | – | 1.89% | – |
BKS | New | BARNES & NOBLE INC | $13,965,000 | – | 875,000 | – | 1.89% | – |
ITMN | New | INTERMUNE INC | $13,228,000 | – | 1,375,000 | – | 1.79% | – |
LBTYK | New | LIBERTY GLOBAL PLC-SERIES Ccl c | $11,491,000 | – | 169,254 | – | 1.56% | – |
WCRX | New | WARNER CHILCOTT PLC-CL A | $11,268,000 | – | 566,000 | – | 1.53% | – |
OREX | New | OREXIGEN THERAPEUTICS INC | $11,106,000 | – | 1,900,000 | – | 1.50% | – |
OPTR | New | OPTIMER PHARMACEUTICALS INC | $6,873,000 | – | 475,000 | – | 0.93% | – |
UHS | New | UNIVERSAL HEALTH SERVICES-Bcl b | $6,696,000 | – | 100,000 | – | 0.91% | – |
SHPG | New | SHIRE PLC-ADRadr | $6,658,000 | – | 70,000 | – | 0.90% | – |
BMC | New | BMC SOFTWARE INC | $6,634,000 | – | 147,000 | – | 0.90% | – |
ALNY | New | ALNYLAM PHARMACEUTICALS INC | $4,484,000 | – | 144,647 | – | 0.61% | – |
ECYT | New | ENDOCYTE INC | $4,399,000 | – | 335,000 | – | 0.60% | – |
NDAQ | New | NASDAQ OMX GROUP/THE | $4,092,000 | – | 124,793 | – | 0.55% | – |
INFI | New | INFINITY PHARMACEUTICALS INC | $4,048,000 | – | 250,000 | – | 0.55% | – |
APC | New | ANADARKO PETROLEUM CORP | $3,609,000 | – | 42,000 | – | 0.49% | – |
NBIX | New | NEUROCRINE BIOSCIENCES INC | $3,613,000 | – | 270,000 | – | 0.49% | – |
MU | New | MICRON TECHNOLOGY INC | $3,325,000 | – | 232,000 | – | 0.45% | – |
BAC | New | BANK OF AMERICA CORP | $3,138,000 | – | 244,000 | – | 0.42% | – |
RIGL | New | RIGEL PHARMACEUTICALS INC | $3,006,000 | – | 900,000 | – | 0.41% | – |
SQNM | New | SEQUENOM INC | $2,947,000 | – | 700,000 | – | 0.40% | – |
VALE | New | VALE SA-SP ADRadr | $2,885,000 | – | 219,400 | – | 0.39% | – |
PACD | New | PACIFIC DRILLING SA | $2,690,000 | – | 275,000 | – | 0.36% | – |
DAL | New | DELTA AIR LINES INC | $2,320,000 | – | 124,000 | – | 0.31% | – |
HAL | New | HALLIBURTON CO | $2,295,000 | – | 55,000 | – | 0.31% | – |
CCL | New | CARNIVAL CORPctf | $1,564,000 | – | 45,600 | – | 0.21% | – |
MSFT | New | MICROSOFT CORP | $691,000 | – | 20,000 | – | 0.09% | – |